LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p
X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang Department of Medical Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Since this paper presents several inaccuracies and mistakes, the article “LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p, by X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (24): 10761-10768–DOI: 10.26355/eurrev_201912_19778–PMID: 31858543” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/19778
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang
LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 6
Pages: 2462-2462
DOI: 10.26355/eurrev_202103_25402